Core Viewpoint - Nature's Sunshine Products, Inc. reported a strong second quarter for 2025, with net sales of $115 million and adjusted EBITDA of $11 million, reflecting year-over-year increases of 4% and 8% respectively, driven by growth in Japan, Central Europe, and digital business initiatives [2][7]. Financial Performance - Net sales for the second quarter of 2025 were $114.8 million, up from $110.6 million in the same quarter of 2024, marking a 4% increase. Excluding foreign exchange impacts, net sales increased by 2% [3][7]. - Adjusted EBITDA rose to $11.3 million, an 8% increase from $10.4 million in the prior year quarter, primarily due to higher net sales [10]. - GAAP net income attributable to common shareholders increased to $5.3 million, or $0.28 per diluted share, compared to $1.3 million, or $0.07 per diluted share, in the same quarter of 2024 [9][10]. Segment Performance - Sales by region showed varied performance: - Asia: $52.7 million, up 5.4% - Europe: $21.7 million, up 0.6% - North America: $35.0 million, up 4.2% - Latin America and Other: $5.4 million, down 0.6% [3]. Cost and Expenses - Gross profit margin improved to 71.7% from 71.4% year-over-year, attributed to cost-saving initiatives despite foreign exchange challenges [4]. - Selling, general and administrative expenses (SG&A) increased to $43.7 million from $38.6 million, representing 38.1% of net sales compared to 34.9% in the previous year [5]. Income and Cash Flow - Operating income decreased to $4.3 million, or 3.7% of net sales, down from $5.6 million, or 5.1% of net sales, in the prior year [6]. - Net cash provided by operating activities for the first half of 2025 was $6.9 million, compared to $3.5 million in the same period of 2024 [11]. Outlook - The company expects full-year 2025 net sales to range between $460 million and $475 million, and adjusted EBITDA to range between $41 million and $45 million, reflecting an optimistic outlook despite macroeconomic uncertainties [12].